News in Numbers
€95m
Valneva sold a priority review voucher, which it received when its chikungunya vaccine, Ixchiq, got FDA approval in November 2023, to an undisclosed party for €95m ($103m).
6.4%
AbbVie reported $54.32bn in net FY2023 revenues, a 6.4% drop compared to the previous year.
$300m
AstraZeneca is investing $300m in a facility in Rockville, Maryland, marking a significant step in launching its cell therapy platforms in the US.
2
The European Medicines Agency has selected two participants developing gene therapies— Berlin Center for Advanced Therapies and Fondazione Telethon in a pilot program to encourage non-commercial developers of advanced therapy medicinal products.
20m
As per the World Health Organization, there were an estimated 20 million new cancer cases and 9.7 million deaths, in 2022.
